NCT03873961

Brief Summary

The aim of this study is to evaluate and compare the changes of heel pain, functional health and well-being after high-intensity and low-level laser therapy for plantar fasciitis or Achilles tendinopathy

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
155

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jan 2017

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 3, 2017

Completed
2.2 years until next milestone

First Submitted

Initial submission to the registry

March 3, 2019

Completed
11 days until next milestone

First Posted

Study publicly available on registry

March 14, 2019

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2019

Completed
Last Updated

March 17, 2020

Status Verified

March 1, 2020

Enrollment Period

2.3 years

First QC Date

March 3, 2019

Last Update Submit

March 14, 2020

Conditions

Keywords

High-Intensity Laser TherapyLow-level Laser Therapy

Outcome Measures

Primary Outcomes (3)

  • Pain - visual analog scale

    Visual analog scale from 0 to 100 mm ("0" = no pain, "100" = the most intense pain). Heel pain in specific day time (at rest, first morning step, several minutes after first step, first step after prolonged sitting in the middle of the day, in the evening and at night)

    Baseline

  • Pain - visual analog scale

    Visual analog scale from 0 to 100 mm ("0" = no pain, "100" = the most intense pain). Heel pain in specific day time (at rest, first morning step, several minutes after first step, first step after prolonged sitting in the middle of the day, in the evening and at night)

    After 3 weeks of treatment

  • Pain - visual analog scale

    Visual analog scale from 0 to 100 mm ("0" = no pain, "100" = the most intense pain). Heel pain in specific day time (at rest, first morning step, several minutes after first step, first step after prolonged sitting in the middle of the day, in the evening and at night)

    4 weeks follow up

Secondary Outcomes (7)

  • Pain - pressure algometry

    Baseline to 3 weeks and 4 weeks follow up

  • Range of motion - goniometry

    Baseline to 3 weeks and 4 weeks follow up

  • Tendon thickness measurement - ultrasound

    Baseline to 3 weeks and 4 weeks follow up

  • Functional health and well-being - SF-36v2®

    Baseline to 3 weeks and 4 weeks follow up

  • Evaluation of functional condition of patients' feet - Foot Function Index-Revised Short Form

    Baseline to 3 weeks and 4 weeks follow up

  • +2 more secondary outcomes

Study Arms (2)

High-intensity laser therapy

EXPERIMENTAL

The participants received stretching and exercise guidance and underwent the BTL-6000 High Intensity Laser 12 W with 10 mm pen applicator high intensity laser procedures (mode = continuous, power = 7 W, dose = 120 J/cm2, total time= 7 min. 8 sec.) 3 times per week (total of 8 procedures).

Device: High-intensity laser therapy

Low-level laser therapy

ACTIVE COMPARATOR

The participants received stretching and exercise guidance underwent the LAS-Expert with laser shower applicator Low-level Laser therapy procedures (785 nm wavelength, 4,0 J/cm2, 35cm2, 6:40 min) 3 times per week (total of 8 procedures).

Device: Low-level Laser therapy

Interventions

tissue photobiostimulation for pain reduction and healing enhancement.

Also known as: BTL-6000 High Intensity Laser 12 W with 10 mm pen
High-intensity laser therapy

tissue photobiostimulation for pain reduction and healing enhancement.

Also known as: LAS-Expert with laser shower
Low-level laser therapy

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • unilateral painful activity related symptoms from the Achilles region
  • tenderness during palpation of Achilles insertion on calcaneus or couple centimeters above
  • unilateral plantar heel pain, mainly during the first few steps upon rising in the morning
  • tenderness at the insertion site of the plantar fascia o the calcaneus

You may not qualify if:

  • bilateral heel pain
  • other acute pathology (febrile fever, cold. etc.) that require treatment
  • other painful conditions that require painkillers (tooth pain, back pain, etc)
  • pregnancy
  • history of recent trauma or foot surgery
  • wounds, infections in treatment area
  • impaired sensation in treatment area
  • pigmentation changes on the skin in treatment area (tattoo, birthmarks)
  • received oral or injected corticosteroids within the last 26 weeks
  • diagnosis of systemic inflammatory arthritis (goat, rheumatoid arthritis, etc)
  • diagnosis of neurological heel pain (radiculopathy)
  • diagnosis of other heel pathology (calcaneal stress fracture, osteomyelitis, plantar fascia neoplasm, plantar fascia rupture, etc)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Lithuanian University of Health Sciences, Department of Rehabilitation

Kaunas, LT 44307, Lithuania

Location

MeSH Terms

Interventions

Low-Level Light Therapy

Intervention Hierarchy (Ancestors)

Laser TherapyTherapeuticsPhototherapy

Study Officials

  • Raimondas Kubilius, professor

    Lithuanian University of Health Sciences

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Participants were informed that they will receive treatment with laser. Participants were not informed which laser (HILT or LLLT) was administered.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Doctor of Medicine, investigator

Study Record Dates

First Submitted

March 3, 2019

First Posted

March 14, 2019

Study Start

January 3, 2017

Primary Completion

April 30, 2019

Study Completion

April 30, 2019

Last Updated

March 17, 2020

Record last verified: 2020-03

Locations